Jincheng Medicine: Subsidiary received approval notification letter for drug supplement application.

Jincheng Pharmaceutical announced that its holding subsidiary, Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., recently received the "Drug Supplementary Application Approval Notice" for Cefuroxime Sodium for Injection issued by the National Medical Products Administration. The drug approval conclusion is to approve changes to the registration standards of the product, with quality standards in accordance with the attached documents and other approvals to be implemented as originally approved. The relevant changes should be implemented within 6 months from the date of approval.